Ingevity Co. (NYSE:NGVT) Shares Purchased by Moody National Bank Trust Division

Moody National Bank Trust Division boosted its position in Ingevity Co. (NYSE:NGVT) by 12.4% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 41,837 shares of the company’s stock after acquiring an additional 4,608 shares during the period. Moody National Bank Trust Division owned about 0.12% of Ingevity worth $1,705,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of NGVT. Choreo LLC acquired a new stake in shares of Ingevity in the second quarter worth approximately $474,000. Headlands Technologies LLC purchased a new stake in shares of Ingevity during the 2nd quarter valued at $46,000. American Century Companies Inc. raised its position in shares of Ingevity by 7.6% in the 2nd quarter. American Century Companies Inc. now owns 765,588 shares of the company’s stock worth $33,464,000 after buying an additional 53,839 shares during the period. Federated Hermes Inc. acquired a new position in Ingevity in the second quarter valued at $916,000. Finally, Oppenheimer Asset Management Inc. grew its position in Ingevity by 17.5% during the second quarter. Oppenheimer Asset Management Inc. now owns 25,426 shares of the company’s stock valued at $1,111,000 after acquiring an additional 3,784 shares during the period. 91.59% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, BMO Capital Markets lifted their price objective on Ingevity from $40.00 to $47.00 and gave the company a “market perform” rating in a research note on Thursday, October 31st. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $52.17.

Ingevity Trading Up 4.4 %

NYSE:NGVT opened at $39.68 on Tuesday. Ingevity Co. has a 12 month low of $30.90 and a 12 month high of $56.29. The business’s 50-day moving average is $44.23 and its two-hundred day moving average is $40.71. The company has a debt-to-equity ratio of 6.52, a current ratio of 1.76 and a quick ratio of 1.04. The firm has a market capitalization of $1.44 billion, a PE ratio of -2.56 and a beta of 1.65.

Ingevity (NYSE:NGVT) last released its quarterly earnings results on Tuesday, October 29th. The company reported $1.10 EPS for the quarter, topping the consensus estimate of $0.60 by $0.50. Ingevity had a positive return on equity of 24.46% and a negative net margin of 38.11%. The firm had revenue of $376.90 million for the quarter, compared to analyst estimates of $376.95 million. During the same period in the previous year, the company posted $1.21 EPS. Ingevity’s revenue for the quarter was down 15.5% on a year-over-year basis. Research analysts predict that Ingevity Co. will post 2.55 earnings per share for the current fiscal year.

About Ingevity

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.